Antibodies News and Research

RSS
Novel approach to DNA synthesis could help tackle COVID-19 pandemic

Novel approach to DNA synthesis could help tackle COVID-19 pandemic

Houston Methodist receives FDA approval to transfuse donated plasma into a COVID-19 patient

Houston Methodist receives FDA approval to transfuse donated plasma into a COVID-19 patient

Zebrafish can provide genetic clues to human nicotine addiction

Zebrafish can provide genetic clues to human nicotine addiction

Scientists model human CMV-induced microcephaly using brain organoids

Scientists model human CMV-induced microcephaly using brain organoids

How long to a coronavirus vaccine?

How long to a coronavirus vaccine?

Research characterizes iPS87 cell line as cancer-inducing, stem cell-like cell line

Research characterizes iPS87 cell line as cancer-inducing, stem cell-like cell line

New drug shows promise to reverse treatment resistance in advanced multiple myeloma

New drug shows promise to reverse treatment resistance in advanced multiple myeloma

Research offers hope for increasing the robustness of vaccine response in older people

Research offers hope for increasing the robustness of vaccine response in older people

Scientists uncover key molecular mechanism underlying different aspects of sepsis

Scientists uncover key molecular mechanism underlying different aspects of sepsis

A promising strategy to overcome drug resistance developed by blood cancer cells

A promising strategy to overcome drug resistance developed by blood cancer cells

Berkeley Lights Announces GEPAD to Attack COVID-19 and Other Viruses

Berkeley Lights Announces GEPAD to Attack COVID-19 and Other Viruses

Deleting a gene prevents Type 1 diabetes in mice by disguising insulin-producing cells

Deleting a gene prevents Type 1 diabetes in mice by disguising insulin-producing cells

Drebrin autoantibodies trigger epilepsy

Drebrin autoantibodies trigger epilepsy

Projects to develop COVID-19 vaccines receive U.K. gov’t funding

Projects to develop COVID-19 vaccines receive U.K. gov’t funding

Celltrion announces key milestones in its efforts to fight COVID-19

Celltrion announces key milestones in its efforts to fight COVID-19

CEL-SCI collaborates with UGA Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy

CEL-SCI collaborates with UGA Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy

NYUAD researchers develop new microfluidic platform to perform cancer liquid biopsies

NYUAD researchers develop new microfluidic platform to perform cancer liquid biopsies

The COVID-19 vaccine pipeline

The COVID-19 vaccine pipeline

Patients treated with ACEIs and ARBs may be at increased risk of severe COVID-19

Patients treated with ACEIs and ARBs may be at increased risk of severe COVID-19

DSI alumni use computational design to quickly discover treatments for COVID-19

DSI alumni use computational design to quickly discover treatments for COVID-19

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.